Copernicus Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$711K Buy
2021
Q2
$868K Buy
2021
Q1
$660K Buy
2020
Q4
$295K Sell
2020
Q3
$6.13M Sell
2020
Q2
$5.33M Sell
2020
Q1
$3.58M Sell
2019
Q4
$3.17M Buy
2019
Q3
$1.17M Buy